EN
HI
Suven Life Sciences Chart
Suven Life Sciences Share Key Metrics
Volume
11.46 L
Market Cap
3893.08 CR
LTQ@LTP
946@167.84
ATP
161.79
Var Margin
25.77 %
Circuit Range
126.37-189.55
Delivery %
30.29 %
Value
18.54 CR
ASM/GSM
No
Market Lot
1
Summary
At 6 Apr, 2026 | 15:54, Suven Life Sciences share price stands at ₹167.84, showing a 9.88% 6.25 for the day. The stock’s intraday movement has stayed between ₹152.51 and ₹171.52, while on a 52-week basis it has fluctuated from ₹113.99 to ₹299.99.
In terms of trading activity, Suven Life Sciences has recorded a volume of 1145739 shares, with a market capitalisation of ₹231951819. The stock’s Average Traded Price (ATP) stands at ₹16179, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 946,16784. The stock operates within a circuit range of ₹126.37-189.55, with a Value of ₹18.54 CR. The Delivery Percentage for the day is 30.29%. Additionally, Suven Life Sciences currently falls under the No framework, and trades with a market lot size of 1.
Suven Life Sciences Fundamentals
View MoreP/E Ratio
0
P/B Ratio
6.24
Div. Yield
0
Sector P/E
60.59
Sector P/B
3.25
Sec. Div. Yield
0.59
Suven Life Sciences Resistance and Support
Pivot 153.42
Resistance
First Resistance
166.54
Second Resistance
175.12
Third Resistance
188.24
Support
First Support
144.84
Second Support
131.72
Third Support
123.14
Suven Life Sciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-01-29 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-05-13 | Audited Results & Preferential issue |
| 2025-01-24 | Quarterly Results |
Suven Life Sciences News
Suven Life Sciences Ltd - 530239 - Closure of Trading Window
Suven Life Sciences board will convene to consider the audited financial results for Q4 and the full fiscal year ended March 31, 2026. The specific date for this meeting will be communicated shortly.
Mar 25 2026 17:03:00
Suven Life Sciences Ltd - 530239 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Jasti Property and Equity Holdings, a promoter group entity, increased its holding in Suven Life Sciences to 70.15% after converting 31.76 million warrants into equity shares. This acquisition, made via preferential allotment, strengthens promoter confidence and aligns with SEBI regulations on lock-in periods.
Mar 09 2026 16:03:00
Read More
About Suven Life Sciences
NSE : 11233
BSE : 530239
ISIN : INE495B01038
Suven Pharmaceuticals Limited was promoted in 1989 byMr.Jasti Venkateswarlu and Mrs. Jasti Sudha Rani for themanufacture of bulk drugs and drug intermediates. TheCompany was incorporated as a Private Limited Company on9th March 1989 in the state of Andhra Pradesh.Subsequently on 4th January 1995 it was converted into aPublic Limited Company in terms of special resolution dated25.11.94 U/s. 31(1)/44 of Companies Act.
Suven Life Sciences Management
| Name | Position |
|---|---|
| Mr. Venkateswarlu Jasti | Chairman & Managing Director |
| Mrs. Sudharani Jasti | Whole Time Director |
Suven Life Sciences Similar Stocks
Thyrocare Technologies Ltd.
379.45
13.45 (3.67%)
FDC Ltd.
336.90
3.65 (1.10%)
Nephrocare Health Services Ltd.
525.90
-2.70 (0.51%)
Supriya Lifescience Ltd.
615.55
3.35 (0.55%)
Innova Captab Ltd.
699.50
-4.90 (0.70%)
Indraprastha Medical Corporation Ltd.
410.85
11.25 (2.82%)
SMS Pharmaceuticals Ltd.
390.55
2.30 (0.59%)
Senores Pharmaceuticals Ltd.
778.15
-6.10 (0.78%)
Artemis Medicare Services Ltd.
229.53
5.32 (2.37%)
Suven Life Sciences FAQs
The Buying Price of Suven Life Sciences share is 167.84 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Suven Life Sciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Suven Life Sciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Suven Life Sciences shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Suven Life Sciences shares is 6.24. Useful to assess the stock's value relative to its book value.
To assess Suven Life Sciences’s valuation compare Sector P/E, P/B which are 60.59 & 3.25 with sector averages, along with growth rates and financial metrics.
The Market Cap of Suven Life Sciences is 3893.08 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Suven Life Sciences share price is 299.99 & 113.99. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Suven Life Sciences belongs to the Healthcare sector.
